Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Kurt A Jellinger, Amos D Korczyn
https://pubmed.ncbi.nlm.nih.gov/29510692/Actively Recruiting
Led by University Hospital, Bonn · Updated on 2026-01-16
130
Participants Needed
1
Research Sites
52 weeks
Total Duration
Alpha-synucleinopathies, including Parkinsons disease and dementia with Lewy bodies, are common neurodegenerative diseases characterized by motor decline and cognitive impairment. Isolated REM sleep behavior disorder iRBD is an early sign of these diseases before significant motor or cognitive symptoms appear. This research aims to study whether increasing physical activity in daily life can help preserve cognitive functions in individuals with iRBD, using a randomized, double-blind, actively controlled trial design conducted over one year. Participants will use a motivational smartphone application called Alpha-Fit to increase their physical activity based on their baseline levels. The study compares two groups with different activity goals one aiming to double their baseline step count and moderate to vigorous physical activity, and the other aiming for a smaller increase of about 10%. The intervention lasts 12 months, with the app providing feedback and support to encourage reaching individual goals. During the study, participants undergo neuropsychological tests to assess cognitive performance as the primary outcome. Secondary assessments include motor function tests, sleep quality evaluation through polysomnography, blood markers related to metabolism, neurodegeneration, and inflammation, as well as brain imaging by MRI. The study recruits 80 individuals with iRBD and 50 healthy controls aged 50 to 80 years. Participants progress and safety are monitored throughout the 12 months, including adherence to physical activity goals and any changes in clinical or biological markers.
CONDITIONS
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
M
Martin M Rodemann
E
Emily L Fitzgibbon, M.Sc.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Bonn
Lead Sponsor
Radboud University Medical Center
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 months
Participants use a motivational smartphone application to increase their physical activity levels over a period of 12 months, with different activity goals depending on their assigned group.
Regular app use with periodic assessments (visit details not specified)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Kurt A Jellinger, Amos D Korczyn
https://pubmed.ncbi.nlm.nih.gov/29510692/E Ray Dorsey, Todd Sherer, Michael S Okun...
https://pubmed.ncbi.nlm.nih.gov/30584159/Matteo Cesari, Anna Heidbreder, Erik K St Louis...
https://pubmed.ncbi.nlm.nih.gov/34694408/Xuexian Fang, Dan Han, Qi Cheng...
https://pubmed.ncbi.nlm.nih.gov/30646166/Edward S Bliss, Rachel Hx Wong, Peter Rc Howe...
https://pubmed.ncbi.nlm.nih.gov/32954902/Jules M Janssen Daalen, Sabine Schootemeijer, Edo Richard...
https://pubmed.ncbi.nlm.nih.gov/35970584/Nienke M de Vries, Sirwan K L Darweesh, Bastiaan R Bloem
https://pubmed.ncbi.nlm.nih.gov/34724528/Dag Aarsland, Lucia Batzu, Glenda M Halliday...
https://pubmed.ncbi.nlm.nih.gov/34210995/Ryul Kim, Tae Lee Lee, Hanall Lee...
https://pubmed.ncbi.nlm.nih.gov/37922635/Daniela Berg, Per Borghammer, Seyed-Mohammad Fereshtehnejad...
https://pubmed.ncbi.nlm.nih.gov/33879872/University Hospital, Bonn
Lead Sponsor
Radboud University Medical Center
Collaborating Sponsor